David Moher

Research.com Recognitions

• 2023 - Research.com Medicine in Canada Leader Award

Overview

Best Publications

• Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

  David Moher;David Moher;Alessandro Liberati;Jennifer Tetzlaff;Douglas G. Altman

  132473
  Citations

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

  David Moher;David Moher;Alessandro Liberati;Jennifer Tetzlaff;Douglas G. Altman

  97407
  Citations

• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  Alessandro Liberati;Douglas G. Altman;Jennifer Tetzlaff;Cynthia Mulrow

  76216
  Citations

• PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

  Andrea C Tricco;Erin Lillie;Wasifa Zarin;Kelly K O'Brien

  36604
  Citations

• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

  Julian P T Higgins;Douglas G Altman;Peter C Gøtzsche;Peter Jüni

  29485
  Citations

• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

  David Moher;Larissa Shamseer;Mike Clarke;Davina Ghersi

  25258
  Citations

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

  Alessandro Liberati;Douglas G Altman;Jennifer Tetzlaff;Cynthia Mulrow

  22464
  Citations

• Meta-analysis of observational studies in epidemiology - A proposal for reporting

  D F Stroup;J A Berlin;S C Morton;I Olkin

  22264
  Citations

• CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

  K F Schulz;D G Altman;D Moher

  18588
  Citations

• CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

  Kenneth F Schulz;Douglas G Altman;David Moher;David Moher

  16869
  Citations

• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement

  David Moher;Deborah J Cook;Susan Eastwood;Ingram Olkin

  13625
  Citations

• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

  D Moher;A Liberati;J Tetzlaff;D G Altman

  13172
  Citations

• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

  Larissa Shamseer;David Moher;Mike Clarke;Davina Ghersi

  12968
  Citations

• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

  P M Bossuyt;J B Reitsma;D E Bruns;C A Gatsonis

  12491
  Citations

• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

  D Moher;K F Schulz;D G Altman

  11172
  Citations

• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

  David Moher;Sally Hopewell;Kenneth F Schulz;Victor M. Montori

  10265
  Citations

• Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide

  Tammy C Hoffmann;Paul P Glasziou;Isabelle Boutron;Ruairidh Milne

  10144
  Citations

• Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

  Don Husereau;Michael Drummond;Stavros Petrou;Chris Carswell

  8733
  Citations

• The consort statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials

  D Moher;K F Schulz;D Altman

  8043
  Citations

• AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

  Beverley J Shea;Beverley J Shea;Barnaby C Reeves;George Wells;Micere Thuku

  7533
  Citations